草包医生
Lv2
140 积分
2022-08-30 加入
-
A Mucin 16 bispecific T cell–engaging antibody for the treatment of ovarian cancer
10天前
已完结
-
Addition of ramucirumab enhances docetaxel efficacy in patients who had received anti-PD-1/PD-L1 treatment
23天前
已完结
-
Multicentre real-world data of ramucirumab plus docetaxel after combined platinum-based chemotherapy with programmed death-1 blockade in advanced non-small cell lung cancer: NEJ051 (REACTIVE study)
23天前
已完结
-
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
3个月前
已完结
-
A phase I, dose-escalation study of PF-06650808, an anti-Notch3 antibody–drug conjugate, in patients with breast cancer and other advanced solid tumors
7个月前
已完结
-
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
7个月前
已完结
-
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
7个月前
已完结
-
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study
8个月前
已完结
-
Advances and challenges in targeting FGFR signalling in cancer
8个月前
已完结
-
免疫检查点抑制剂相关神经不良反应诊治中国专家共识(2022版)
8个月前
已完结